Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.

ABSTRACT:

Background

The rate and composition of bacterial co-infection in patients with coronavirus disease 2019 (COVID-19) were evaluated when microbiological testing was conducted on the majority of patients. We also evaluated whether the use of empirical antibacterials was associated with mortality.

Methods

In this retrospective study, all of the adult patients with COVID-19 hospitalized in a single tertiary hospital in South Korea between February 2020 and December 2021 were included. Bacterial co-infection was assessed by sputum cultures, blood cultures, and molecular testing, including polymerase chain reaction sputum testing and urinary antigen tests. Mortality was compared between patients who received empirical antibacterials and those who did not.

Results

Of the 367

SUBMITTER: Lee J 

PROVIDER: S-EPMC9886529 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature